What they were paid
REGENXBIO Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $65,000 | $68,747 | $206,247 | $0 | $339,994 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: REGENXBIO Inc. DEF 14A filed April 14, 2026, accession 0001193125-26-155058, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025REGENXBIO pays directors a $45,000 cash retainer and $275,000 in Options and RSUs.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the REGENXBIO board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| A.N. Jerry Karabelas | Independent Director | $327,494 |
| Alexandra Glucksmann | Independent Director | $327,494 |
| Allan M. Fox | Independent Director | $319,994 |
| Curran Simpson | Director | $0 |
| Daniel Tass | Lead Independent Director | — |
| George Migausky | Independent Director | $339,994 |
| Jean Bennett | Independent Director | $324,994 |
| Jennifer Zachary | Independent Director | $329,994 |
| Kenneth T. Mills | Chair of the Board | $354,994 |
The full REGENXBIO compensation record
free company briefThis page is one director within REGENXBIO's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat